A group of our L6 students have been researching non-small cell lung cancer for Imperial's Science in Medicine School Team Prize and have been working on a poster that focuses on a new innovation that would theoretically reduce the death rate. Their concept involves using machine learning in AI to diagnose the disease earlier with the use of mucus as its training data. It is a combination of blood based liquid biopsy and lab testing with sputum cytology, but hopefully with higher precision and wider availability. 

They are hoping for a specialist's opinion. If you have any experience within the field of AI and medicine, could you help by offering to read through their proposal, see if it would be feasible, and provide any thoughts and advice, or direct them towards someone who could help?

Please email oga@stswithuns.com if you think you could help.